Skip to main content
Fig. 5 | BMC Infectious Diseases

Fig. 5

From: Evaluation of serological lateral flow assays for severe acute respiratory syndrome coronavirus-2

Fig. 5

Example image of the interactive webapp hosted at https://covid.omics.kitchen. Using the sliders, one is able to visualize the effect of changing the disease prevalence (and the test performance) on the resulting probability that, given a positive LFA test, the individual does in fact have SARS-CoV-2 antibodies. The figure shows an example of positive predictive value using the US national prevalence of 5% (on November 27th, 2020) and the performance characteristics of the InTec LFA

Back to article page